PROGRESSIVE ANGIOPLASTY SYSTEMS ENTERS U.S. PTCA MARKET WITH LACROSSE CATHETER; NEXT GENERATION CHAMPION PMA SUPPLEMENT PENDING AT FDA
This article was originally published in The Gray Sheet
Executive Summary
Progressive Angioplasty Systems, Inc. has begun shipping its first device in the U.S., the PAS LaCrosse over-the-wire percutaneous transluminal coronary angioplasty catheter, following FDA premarket approval on Sept. 27.